Home › Funds › Birchview Capital, LP › SLDB

Birchview Capital, LP position in SLDB

SOLID BIOSCIENCES INC · Health Care

Birchview Capital, LP reported holding 715,955 shares of SLDB (SOLID BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$5.2M, representing 3.08% of its reported portfolio and ranking #8 among its reported holdings. Birchview Capital, LP has disclosed SLDB holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)715.96K sh
Reported value held$5.18M
Portfolio Weight3.08%
First reportedQ1 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's SLDB position evolved

Birchview Capital, LP first disclosed a stake in SLDB in Q1 2025 at 128,768 shares (US$476K). The position peaked in Q2 2026 at 666,196 shares, worth US$6.7M. Across 7 filings, Birchview Capital, LP increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 715,955 shares valued at US$5.2M — an increase of 49,759 shares quarter over quarter.. Notable position changes include a 39% increase in Q2 2025 (shares rose 27% over the following quarter), a 66% increase in Q3 2025 (shares fell 9% over the following quarter), a 138% increase in Q4 2025 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 128.77K $476.44K New
Q2 2025 178.77K $870.60K Add
Q3 2025 296.95K $1.83M Add
Q4 2025 705.96K $3.98M Add
Q1 2026 625.98K $4.51M Reduce
Q2 2026 666.20K $6.66M Add
Q3 2026 715.96K $5.18M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLDB and 13F data

SLDB (SOLID BIOSCIENCES INC) is a Health Care company. 46 other funds we track also report a position in SLDB — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$120.2M), PERCEPTIVE ADVISORS LLC (US$118.9M), Bain Capital Life Sciences Investors, LLC (US$98.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLDB

All SLDB fund holders →

FAQ

How long has Birchview Capital, LP held SLDB?

Birchview Capital, LP has disclosed SLDB holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Birchview Capital, LP's current position in SLDB?

As of Q3 2026, Birchview Capital, LP holds 715.96K shares of SLDB (SOLID BIOSCIENCES INC), valued at $5.18M, representing 3.08% of its reported portfolio and ranking #8.

Has Birchview Capital, LP been buying or selling SLDB?

In the latest 13F filing (Q3 2026), Birchview Capital, LP increased its position in SLDB. The position peaked in Q2 2026 at 666.20K shares.

Which other funds hold SLDB?

Other major institutional holders of SLDB include RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.